SCHEMBL80917

SCHEMBL80917

CC1(C)c2ccc(-c3ccc4c(c3)-c3nc(-c5ccccc5)ccc3C4(C)C)cc2-c2nc(-c3ccccc3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
ALDH1A1 P00352 7/20 0.39
MAPT P10636 6/20 0.39
KDM4E B2RXH2 5/20 0.39
RAB9A P51151 3/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
RARA P10276 1/20 0.35
RARB P10826 1/20 0.35
HPGD P15428 4/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TSHR P16473 1/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PGR P06401 1/20 0.34
NPC1 O15118 1/20 0.34
HSD17B10 Q99714 2/20 0.33
ADORA2A P29274 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82098 0.89 RARB (0.35) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL80760 0.89 PDK2 (0.42) MEN1KMT2AMAPTRAB9AL3MBTL1
SCHEMBL81231 0.88 KMT2A (0.34) MEN1KMT2AMAPTRAB9ARARB
SCHEMBL81689 0.87 RARA (0.33) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL2512872 0.87 RAB9A (0.39) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL80233 0.87 PDK2 (0.36)
SCHEMBL80817 0.86 KMT2A (0.33) KMT2AALDH1A1KDM4ERAB9ARARA
SCHEMBL82134 0.86 KMT2A (0.33) KMT2AALDH1A1KDM4ERAB9ARARA
SCHEMBL81037 0.85 MLNR (0.34) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL81165 0.85 KMT2A (0.41) MEN1KMT2AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE AZI2, CYP1A2, CYP2C19 MEN1 1980/4885KMT2A 699/4885ALDH1A1 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.